{
}
Creative Financial Designs Inc. ADV now holds 108 shares of Ecolab, valued at $25,000, after acquiring 62 additional shares last quarter. Institutional investors own 74.91% of Ecolab, which provides water, hygiene, and infection prevention solutions globally. UBS Group raised Ecolab's price target to $280, indicating a potential upside, while analysts maintain a "Moderate Buy" rating with an average target price of $284.33.
UBS has raised its price target on Ecolab Inc. to $280 from $257 while maintaining a neutral rating. Ecolab specializes in cleaning and disinfection products and services across various sectors, including hospitality, healthcare, and food production, with significant sales in the U.S. (53%) and Europe (21%).
Ecolab Inc. specializes in cleaning and disinfection products and services, catering to various sectors including hotels, restaurants, and hospitals. Its operations are divided into wastewater treatment, cleaning and disinfection products, and pest control services. Geographically, net sales are primarily from the United States (53%), followed by Europe (21%) and other regions.
UBS has downgraded Ecolab Inc. from Buy to Neutral, setting a price target of $276, citing diminished stock potential and a balanced risk/reward ratio. Despite a strong track record with 22% annual EPS growth over two years, UBS anticipates a return to a more normalized growth rate of 12-15%, aligning its revised EPS estimates with consensus figures. Ecolab's recent third-quarter results showed a 19% increase in adjusted earnings and a focus on key growth areas, although its high valuation at 34 times next twelve months P/E raises concerns about future performance.
Ecolab's director now holds 24,041 shares valued at approximately $6 million after a recent sale, reflecting no change in ownership percentage. EVP Gregory B. Cook sold 3,811 shares for about $950,000, maintaining a stake of 8,080 shares valued at $2 million. Institutional investors own 74.91% of the company, with recent hedge fund activity showing increased positions. Ecolab was downgraded by UBS Group to a "neutral" rating, with a price target of $276, while analysts maintain a consensus "Moderate Buy" rating.
UBS has downgraded Ecolab (ECL) to Neutral from Buy, maintaining a price target of $276. The firm believes the stock's risk/reward profile is now more balanced, as Ecolab's adjusted earnings growth is expected to return to normal levels, reducing the potential for significant outperformance.
The global Hospital Acquired Infection Control (HAIC) market is projected to grow at a CAGR of about 4% from 2021 to 2027, driven by advancements in sterilization technology and rising awareness of hygiene. The protective barrier segment leads the market, fueled by increasing infection rates and a growing elderly population. North America holds a significant market share, supported by government initiatives and investments in healthcare infrastructure.
The healthcare facilities management market is crucial for enhancing patient experiences through effective service delivery in medical settings. Key players include Sodexo, Serco Group, and Aramark, with market segmentation covering waste management, security, and cleaning services. The report forecasts growth across major regions, highlighting opportunities driven by innovative technologies like IoT.
Ecolab Inc.
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
ecolab sees increased institutional investment and positive analyst ratings
18:33 13.02.2025
ubs raises ecolab price target to 280 maintains neutral rating
Canadian Dollar
Chinese Yuan
Euro
United States Dollar
Indian Rupee
Ecolab Inc.
CHN
IND
USA
CAN
Show more
14:35 12.02.2025
Ecolab Inc. focuses on cleaning and disinfection solutions across various sectors
19:57 22.01.2025
ubs downgrades ecolab shares to neutral and lowers price target
14:56 04.11.2024
Ecolab executives sell shares as institutional investors increase holdings
13:57 04.11.2024
Ecolab downgraded to neutral by UBS amid balanced risk reward outlook
11:02 04.11.2024
global hospital acquired infection control market poised for significant growth
United States Dollar
3M Company
Ecolab Inc.
Reckitt Benckiser Group plc
STERIS plc
FRA
GBR
ITA
ESP
USA
CHN
AUS
JPN
IND
DEU
CAN
Getinge AB
STERIS plc
Ecolab Inc
Advanced Sterilization Products
Sotera Health Company
Show more
12:07 30.10.2024
healthcare facilities management market growth trends and regional analysis to 2031
Sodexo S.A.
OCS Group UK Ltd.
Jones Lang LaSalle Incorporated
Ecolab Inc.
Aramark Corporation
Serco Group plc
Vanguard Resources Inc
ABM Industries Incorporated
Mitie Group plc
Medxcel Facilities Management
Donald Trump
Ankit Mathur
Joe Biden
Show more
23:35 24.10.2024
Trending
Subcategory
Corporate News
Stock Market Updates
Industry Trends
Industry Mergers & Acquisitions
Finance Mergers & Acquisitions
Banking Regulations
Global Trade Developments
Global Financial Events
Domestic Politics
Retail and Consumer Goods
Central Bank Actions
CEO Changes
Government Policies
Market Analysis and Predictions
Startups & Entrepreneurship
Workplace Trends
Elections & Campaigns
Government Economic Policies
Inflation and Monetary Impact
Supply Chain Management
Countries:
Companies:
Tesla, Inc.
JPMorgan Chase & Co.
Barclays PLC
Deutsche Bank Money Market PP
Apple Inc.
UniCredit S.p.A.
Banco BPM S.p.A.
Credit Suisse Strategic Income I
The Goldman Sachs Group, Inc.
SpaceXCoin USD
Lloyds Banking Group plc
BNP Paribas SA
UBS Group AG
Banco Santander, S.A.
CREDIT AGRICOLE
Amazon.com, Inc.
Berkshire Hathaway Inc.
Credit Agricole
Reinsurance Group of America, Incorporated
Google Inc.
Currencies:
United States Dollar
Euro
British Pound Sterling
Swiss Franc
Chinese Yuan
Indian Rupee
Japanese Yen
South Korean Won
Canadian Dollar
Australian Dollar
Offshore Chinese Yuan
Hong Kong Dollar
Singapore Dollar
Mexican Peso
Vietnamese Đồng
Indonesian Rupiah
Thai Baht
Norwegian Krone
Swedish Krona
Filipino Peso
People: